p53-regulated non-apoptotic cell death pathways and their relevance in cancer and other diseases
- PMID: 40204927
- DOI: 10.1038/s41580-025-00842-3
p53-regulated non-apoptotic cell death pathways and their relevance in cancer and other diseases
Abstract
Programmed cell death is a mechanism that is crucial for numerous physiological and pathological processes. Whereas p53-mediated apoptosis is a major cell death pathway in cancer, accumulating evidence indicates that p53 also has crucial roles in controlling different non-apoptotic cell death (NACD) pathways, including ferroptosis, necroptosis, pyroptosis, autophagy-dependent cell death, entotic cell death, parthanatos and paraptosis, and may regulate PANoptosis, cuproptosis and disulfidptosis. Notably, the function of p53 in these NACDs substantially contributes to its biological effects, particularly in cancer development and other pathological processes. In this Review, we discuss recent advances in understanding the roles and underlying mechanisms of p53-mediated NACDs, focusing on ferroptosis, necroptosis and pyroptosis. We discuss the complex and distinct physiological settings in which NACDs are regulated by p53, and potential targeting of p53-regulated NACDs for the treatment of cancer and other human diseases. Finally, we highlight several important questions concerning p53-regulated NACDs that warrant further investigation.
© 2025. Springer Nature Limited.
Conflict of interest statement
Competing interests: B.R.S. is an inventor on patents and patent applications involving ferroptosis; he has co-founded and serves as a consultant to ProJenX, Inc. and Exarta Therapeutics; holds equity in Sonata Therapeutics; serves as a consultant to Weatherwax Biotechnologies Corporation and Akin Gump Strauss Hauer & Feld LLP. X.J. is an inventor on patents related to autophagy and cell death, and holds equity of and consults for Exarta Therapeutics and Lime Therapeutics. The other authors declare no competing interests.
Similar articles
-
Therapeutic Targeting of Apoptosis, Autophagic Cell Death, Necroptosis, Pyroptosis, and Ferroptosis Pathways in Oral Squamous Cell Carcinoma: Molecular Mechanisms and Potential Strategies.Biomedicines. 2025 Jul 16;13(7):1745. doi: 10.3390/biomedicines13071745. Biomedicines. 2025. PMID: 40722814 Free PMC article. Review.
-
Mechanisms and therapeutic potential of multiple forms of programmed cell death in renal fibrosis.Cell Signal. 2025 Oct;134:111926. doi: 10.1016/j.cellsig.2025.111926. Epub 2025 Jun 7. Cell Signal. 2025. PMID: 40490146 Review.
-
Bypassing the guardian: regulated cell death pathways in p53-mutant cancers.Cell Mol Biol Lett. 2025 Jun 14;30(1):68. doi: 10.1186/s11658-025-00751-5. Cell Mol Biol Lett. 2025. PMID: 40517236 Free PMC article. Review.
-
Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns.J Cancer Res Clin Oncol. 2023 Oct;149(13):11351-11368. doi: 10.1007/s00432-023-05000-w. Epub 2023 Jun 28. J Cancer Res Clin Oncol. 2023. PMID: 37378675 Free PMC article.
-
LncRNAs regulates cell death in osteosarcoma.Sci Rep. 2025 Jul 2;15(1):22592. doi: 10.1038/s41598-025-04440-3. Sci Rep. 2025. PMID: 40595878 Free PMC article.
Cited by
-
Bioactive LDH nanoplatforms for cancer therapy: Advances in modulating programmed cell death.Mater Today Bio. 2025 Jul 26;34:102139. doi: 10.1016/j.mtbio.2025.102139. eCollection 2025 Oct. Mater Today Bio. 2025. PMID: 40761508 Free PMC article. Review.
-
Emerging regulated cell death mechanisms in bone remodeling: decoding ferroptosis, cuproptosis, disulfidptosis, and PANoptosis as therapeutic targets for skeletal disorders.Cell Death Discov. 2025 Jul 21;11(1):335. doi: 10.1038/s41420-025-02633-3. Cell Death Discov. 2025. PMID: 40691135 Free PMC article. Review.
-
Characterization of Parthanatos in Breast Cancer: Implications for Prognosis and PARP Inhibitor Resistance.Bioengineering (Basel). 2025 May 29;12(6):586. doi: 10.3390/bioengineering12060586. Bioengineering (Basel). 2025. PMID: 40564403 Free PMC article.
-
Distinct Types of Regulated Cell Death in Melanoma.Cells. 2025 Jun 1;14(11):823. doi: 10.3390/cells14110823. Cells. 2025. PMID: 40497999 Free PMC article. Review.
-
DHODH-mediated mitochondrial redox homeostasis: a novel ferroptosis regulator and promising therapeutic target.Redox Biol. 2025 Jul 23;85:103788. doi: 10.1016/j.redox.2025.103788. Online ahead of print. Redox Biol. 2025. PMID: 40716151 Free PMC article. Review.
References
-
- Hassin, O. & Oren, M. Drugging p53 in cancer: one protein, many targets. Nat. Rev. Drug Discov. 22, 127–144 (2023). - PubMed
-
- Tuval, A., Strandgren, C., Heldin, A., Palomar-Siles, M. & Wiman, K. G. Pharmacological reactivation of p53 in the era of precision anticancer medicine. Nat. Rev. Clin. Oncol. 21, 106–120 (2024). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous